According to our finding of NP, AKT1, CASP3, EGFR, and IGF1 played critical roles in the treatment of SLE with IGU. These target proteins are involved in oxidative stress, inflammation, angiogenesis, and immunomodulator. This evidence concerns the gene CASP3 and systemic lupus erythematosus.